Gene therapy modalities in lung transplantation

Transplant Immunology

Volumn 31, Issue 3, 2014, Pages 165-172

  Rahim, Fakher ^a   Ebrahimi, Ammar ^b  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Gene therapy; Immunomodulation; Immunosuppression; Lung transplantation

Indexed keywords

CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; VIRUS VECTOR;

ACUTE GRAFT REJECTION; ADENO ASSOCIATED VIRUS; ADENOVIRIDAE; ALLOGENEIC STEM CELL TRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; CYTOKINE RELEASE; DNA MODIFICATION; GENE DELIVERY SYSTEM; GENE THERAPY; GRAFT FAILURE; GRAFT SURVIVAL; HERPES SIMPLEX VIRUS; IMMUNOSUPPRESSIVE TREATMENT; LENTIVIRINAE; LUNG TRANSPLANTATION; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; NONVIRAL GENE THERAPY; ORGAN TRANSPLANTATION; RAT; REGULATORY T LYMPHOCYTE; RETROVIRUS; REVIEW; ALLOGRAFT; ANIMAL; GENETICS; GRAFT REJECTION; HUMAN; IMMUNITY; IMMUNOMODULATION; PHYSIOLOGY;

ALLOGRAFTS; ANIMALS; GENETIC THERAPY; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNITY; IMMUNOMODULATION; LUNG TRANSPLANTATION; MODELS, ANIMAL;

EID: 84922477690     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2014.08.001     Document Type: Review

References (95)

1. Nagano H., Tilney N.L. Chronic allograft failure: the clinical problem. Am J Med Sci 1997, 313:305-309.
2. GRoui T.L.T. Unilateral lung transplantation for pulmonary fibrosis. N Engl J Med 1986, 314:1140-1145.
3. Cecka J.M. The UNOS Scientific Renal Transplant Registry-ten years of kidney transplants. Clin Transpl 1997, 1-14.
4. Aiuti A., Slavin S., Aker M., Ficara F., Deola S., Mortellaro A., et al. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 2002, 296:2410-2413.
5. Ott M.G., Schmidt M., Schwarzwaelder K., Stein S., Siler U., Koehl U., et al. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med 2006, 12:401-409.
6. Yang F., Cho S.-W., Son S.M., Bogatyrev S.R., Singh D., Green J.J., et al. Genetic engineering of human stem cells for enhanced angiogenesis using biodegradable polymeric nanoparticles. Proc Natl Acad Sci 2010, 107:3317-3322.
7. Sokolova V., Epple M. Inorganic nanoparticles as carriers of nucleic acids into cells. Angew Chem Int Ed 2008, 47:1382-1395.
8. Yamashita S., Fukushima H., Akiyama Y., Niidome Y., Mori T., Katayama Y., et al. Controlled-release system of single-stranded DNA triggered by the photothermal effect of gold nanorods and its in vivo application. Bioorg Med Chem 2011, 19:2130-2135.
9. Walther W., Stein U. Viral vectors for gene transfer: a review of their use in the treatment of human diseases. Drugs 2000, 60:249-271.
10. Marshall E. Gene therapy death prompts review of adenovirus vector. Science 1999, 286:2244-2245.
11. Hacein-Bey-Abina S., von Kalle C., Schmidt M., Le Deist F., Wulffraat N., McIntyre E., et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2003, 348:255-256.
12. Shayakhmetov D.M., Gaggar A., Ni S., Li Z.-Y., Lieber A. Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity. J Virol 2005, 79:7478-7491.
13. Spear P.G. Herpes simplex virus: receptors and ligands for cell entry. Cell Microbiol 2004, 6:401-410.
14. Edelstein M.L., Abedi M.R., Wixon J. Gene therapy clinical trials worldwide to 2007-an update. J Gene Med 2007, 9:833-842.
15. Kay M.A., Glorioso J.C., Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 2001, 7:33-40.
16. Baum C., Kustikova O., Modlich U., Li Z., Fehse B. Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors. Hum Gene Ther 2006, 17:253-263.
17. Guillot C., Mathieu P., Coathalem H., Le Mauff B., Castro M.G., Tesson L., et al. Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression. J Immunol 2000, 164:5258-5268.
18. Olthoff K.M., Judge T.A., Gelman A.E., Da Shen X., Hancock W.W., Turka L.A., et al. Adenovirus-mediated gene transfer into cold-preserved liver allografts: survival pattern and unresponsiveness following transduction with CTLA4Ig. Nat Med 1998, 4:194-200.
19. Benigni A., Tomasoni S., Turka L.A., Longaretti L., Zentilin L., Mister M., et al. Adeno-associated virus-mediated CTLA4Ig gene transfer protects MHC-mismatched renal allografts from chronic rejection. J Am Soc Nephrol 2006, 17:1665-1672.
20. Oral H., Larkin D., Fehervari Z., Byrnes A., Rankin A., Haskard D., et al. Ex vivo adenovirus-mediated gene transfer and immunomodulatory protein production in human cornea. Gene Ther 1997, 4:639-647.
21. Shiraishi T., Yasunami Y., Takehara M., Uede T., Kawahara K., Shirakusa T. Prevention of acute lung allograft rejection in rat by CTLA4Ig. Am J Transplant 2002, 2:223-228.
22. Feng S., Quickel R.R., Hollister-Lock J., McLeod M., Bonner-Weir S., Mulligan R.C., et al. Prolonged xenograft survival of islets infected with small doses of adenovirus expressing CTLA4Ig1. Transplantation 1999, 67:1607-1613.
23. Guo L., Li X.-k., Enosawa S., Harihara Y., Funeshima N., Kimura H., et al. Prolongation of liver xenograft survival by adenovirus vector-mediated CTLA-4Ig gene transfer. Transpl Immunol 2003, 11:155-162.
24. Li T.-S., Hamano K., Kajiwara K., Nishida M., Zempo N., Esato K. Prolonged survival of xenograft fetal cardiomyocytes by adenovirus-mediated Ctla4-Ig expression1. Transplantation 2001, 72:1983-1985.
25. Tomasoni S., Azzollini N., Casiraghi F., Capogrossi M.C., Remuzzi G., Benigni A. CTLA4Ig gene transfer prolongs survival and induces donor-specific tolerance in a rat renal allograft. J Am Soc Nephrol 2000, 11:747-752.
26. Miao G., Ito T., Uchikoshi F., Akamaru Y., Kiyomoto T., Komodo H., et al. Development of donor-specific immunoregulatory T-cells after local CTLA4Ig gene transfer to pancreatic allograft. Transplantation 2004, 78:59-64.
27. Levisetti M.G., Padrid P., Szot G., Mittal N., Meehan S., Wardrip C., et al. Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation. J Immunol 1997, 159:5187-5191.
28. Kirk A.D., Harlan D.M., Armstrong N.N., Davis T.A., Dong Y., Gray G.S., et al. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci 1997, 94:8789-8794.
29. Fernandes J.R., Duvivier-Kali V.F., Keegan M., Hollister-Lock J., Omer A., Su S., et al. Transplantation of islets transduced with CTLA4-Ig and TGFβusing adenovirus and lentivirus vectors. Transpl Immunol 2004, 13:191-200.
30. Ugurlu M.M., Griffin M.D., O'Brien T., Tazelaar H.D., Miller V.M., McGregor C.G. The effects of CTLA-4Ig on acute lung allograft rejection: a comparison of intrabronchial gene therapy with systemic administration of protein1. Transplantation 2001, 71:1867-1871.
31. Kita Y., Li X.K., Nogimura H., Ida M., Kageyama Y., Ohi S., et al. Prolonged graft survival induced by CTLA4IG gene transfection in rat lung allografting. Transplant Proc 2003, 35:456-457.
32. Qin L., Ding Y., Bromberg J.S. Gene transfer of transforming growth factor-β 1 prolongs murine cardiac allograft survival by inhibiting cell-mediated immunity. Hum Gene Ther 1996, 7:1981-1988.
33. DeBruyne L., Li K., Chan S., Qin L., Bishop D., Bromberg J. Lipid-mediated gene transfer of viral IL-10 prolongs vascularized cardiac allograft survival by inhibiting donor-specific cellular and humoral immune responses. Gene Ther 1998, 5:1079-1087.
34. Boehler A., Chamberlain D., Xing Z., Slutsky A.S., Jordana M., Gauldie J., et al. Adenovirus-mediated interleukin-10 gene transfer inhibits post-transplant fibrous airway obliteration in an animal model of bronchiolitis obliterans. Hum Gene Ther 1998, 9:541-551.
35. Shoji F., Yonemitsu Y., Okano S., Yoshino I., Nakagawa K., Nakashima Y., et al. Airway-directed gene transfer of interleukin-10 using recombinant Sendai virus effectively prevents post-transplant fibrous airway obliteration in mice. Gene Ther 2003, 10:213-218.
36. Tagawa T., Kozower B.D., Kanaan S.A., Daddi N., Muraoka M., Oka T., et al. Gene transfer of tumor necrosis factor inhibitor improves the function of lung allografts. J Thorac Cardiovasc Surg 2004, 127:1558-1563.
37. De Perrot M., Fischer S., Liu M., Imai Y., Martins S., Sakiyama S., et al. Impact of human interleukin-10 on vector-induced inflammation and early graft function in rat lung transplantation. Am J Respir Cell Mol Biol 2003, 28:616-625.
38. Suda T., Daddi N., Tagawa T., Kanaan S.A., Kozower B.D., Ritter J.H., et al. Recipient intramuscular cotransfection of transforming growth factor β1 and interleukin 10 ameliorates acute lung graft rejection. J Thorac Cardiovasc Surg 2005, 129:926-931.
39. Martins S., de Perrot M., Imai Y., Yamane M., Quadri S.M., Segall L., et al. Transbronchial administration of adenoviral-mediated interleukin-10 gene to the donor improves function in a pig lung transplant model. Gene Ther 2004, 11:1786-1796.
40. Sato M., Keshavjee S. Gene therapy in lung transplantation. Curr Gene Ther 2006, 6:439-458.
41. Cypel M., Liu M., Rubacha M., Yeung J.C., Hirayama S., Anraku M., et al. Functional repair of human donor lungs by IL-10 gene therapy. Sci Transl Med 2009, 1:4-9.
42. Yeung J.C., Wagnetz D., Cypel M., Rubacha M., Koike T., Chun Y.M., et al. Ex vivo adenoviral vector gene delivery results in decreased vector-associated inflammation pre- and post-lung transplantation in the pig. Mol Ther 2012, 20:1204-1211.
43. Daddi N., Kanaan S.A., Suda T., Tagawa T., D'Ovidio F., Grapperhaus K., et al. Recipient intramuscular administration of naked plasmid TGF-β1 attenuates lung graft reperfusion injury. J Heart Lung Transplant 2003, 22:1323-1334.
44. Fischer S., De Perrot M., Liu M., MacLean A.A., Cardella J.A., Imai Y., et al. Interleukin 10 gene transfection of donor lungs ameliorates posttransplant cell death by a switch from cellular necrosis to apoptosis. J Thorac Cardiovasc Surg 2003, 126:1174-1180.
45. Pierog J., Gazdhar A., Stammberger U., Gugger M., Hyde S., Mathiesen I., et al. Synergistic effect of low dose Cyclosporine A and human interleukin 10 overexpression on acute rejection in rat lung allotransplantation. Eur J Cardiothorac Surg 2005, 27:1030-1035.
46. Okada Y., Zuo X.J., Toyoda M., Marchevsky A., Matloff J.M., Oishi H., et al. Adenovirus mediated IL-10 gene transfer to the airway of the rat lung for prevention of lung allograft rejection. Transpl Immunol 2006, 16:95-98.
47. Fakin R., Hamacher J., Gugger M., Gazdhar A., Moser H., Alexander Schmid R. Prolonged amelioration of acute lung allograft rejection by sequential overexpression of human interleukin-10 and hepatocyte growth factor in rats. Exp Lung Res 2011, 37:555-562.
48. Hirayama S., Sato M., Loisel-Meyer S., Matsuda Y., Oishi H., Guan Z., et al. Lentivirus IL-10 gene therapy down-regulates IL-17 and attenuates mouse orthotopic lung allograft rejection. Am J Transplant 2013, 13:1586-1593.
49. Oishi H., Okada Y., Kikuchi T., Sado T., Oyaizu T., Hoshikawa Y., et al. Lipid-mediated transbronchial human interleukin-10 gene transfer decreases acute inflammation associated with allograft rejection in a rat model of lung transplantation. Transplant Proc 2007, 39:283-285.
50. Oishi H., Okada Y., Kikuchi T., Sado T., Noda M., Hoshikawa Y., et al. The intensity of bronchiolar epithelial cell injury caused by an alloimmune response is ameliorated by transbronchial human interleukin-10 gene transfer in a rat model of lung transplantation. Surg Today 2011, 41:1458-1460.
51. Tsuchida M., Koike T., Takekubo M., Hirahara H., Hanawa H., Maruyama H., et al. Electroporation-mediated transfer of plasmid DNA encoding IL-10 attenuates orthotopic tracheal allograft stenosis in rats. Transpl Immunol 2008, 19:173-177.
52. Vos I.H., GOVERS R., GRÖNE H.-J., KLEIJ L., SCHURINK M., DE WEGER R.A., et al. NFκB decoy oligodeoxynucleotides reduce monocyte infiltration in renal allografts. FASEB J 2000, 14:815-822.
53. Ishiyama T., Dharmarajan S., Hayama M., Moriya H., Grapperhaus K., Patterson G.A. Inhibition of nuclear factor κB by IκB superrepressor gene transfer ameliorates ischemia-reperfusion injury after experimental lung transplantation. J Thorac Cardiovasc Surg 2005, 130:194-201.
54. Ke B., Coito A.J., Kato H., Zhai Y., Wang T., Sawitzki B., et al. Fas ligand gene transfer prolongs rat renal allograft survival and down-regulates anti-apoptotic Bag-1 in parallel with enhanced Th2-type cytokine expression1. Transplantation 2000, 69:1690-1694.
55. Fallarino F., Grohmann U., You S., McGrath B.C., Cavener D.R., Vacca C., et al. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor ζ-chain and induce a regulatory phenotype in naive T cells. J Immunol 2006, 176:6752-6761.
56. Ghahary A., Li Y., Tredget E.E., Kilani R.T., Iwashina T., Karami A., et al. Expression of indoleamine 2, 3-dioxygenase in dermal fibroblasts functions as a local immunosuppressive factor. J Invest Dermatol 2004, 122:953-964.
57. Vavrincova-Yaghi D., Deelman L.E., Goor H., Seelen M., Kema I.P., Smit-van Oosten A., et al. Gene therapy with adenovirus-delivered indoleamine 2, 3-dioxygenase improves renal function and morphology following allogeneic kidney transplantation in rat. J Gene Med 2011, 13:373-381.
58. Alexander A.M., Crawford M., Bertera S., Rudert W.A., Takikawa O., Robbins P.D., et al. Indoleamine 2, 3-dioxygenase expression in transplanted NOD Islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes. Diabetes 2002, 51:356-365.
59. Liu H., Liu L., Fletcher B.S., Visner G.A. Sleeping Beauty-based gene therapy with indoleamine 2,3-dioxygenase inhibits lung allograft fibrosis. FASEB J 2006, 20:2384-2386.
60. Liu H., Liu L., Fletcher B.S., Visner G.A. Novel action of indoleamine 2,3-dioxygenase attenuating acute lung allograft injury. Am J Respir Crit Care Med 2006, 173:566-572.
61. Liu H., Liu L., Visner G.A. Nonviral gene delivery with indoleamine 2,3-dioxygenase targeting pulmonary endothelium protects against ischemia-reperfusion injury. Am J Transplant 2007, 7:2291-2300.
62. Iken K., Liu K., Liu H., Bizargity P., Wang L., Hancock W.W., et al. Indoleamine 2,3-dioxygenaseand metabolites protect murine lung allografts and impair the calcium mobilization of T cells. Am J Respir Cell Mol Biol 2012, 47:405-416.
63. Vardanian A.J., Busuttil R.W., Kupiec-Weglinski J.W. Molecular mediators of liver ischemia and reperfusion injury: a brief review. Mol Med 2008, 14:337.
64. Hamar P., Song E., Kökény G., Chen A., Ouyang N., Lieberman J. Small interfering RNA targeting Fas protects mice against renal ischemia-reperfusion injury. Proc Natl Acad Sci U S A 2004, 101:14883-14888.
65. Zheng X., Zhang X., Sun H., Feng B., Li M., Chen G., et al. Protection of renal ischemia injury using combination gene silencing of complement 3 and caspase 3 genes. Transplantation 2006, 82:1781-1786.
66. Kita J., Kobayashi E., Hishinuma A., Kaneda Y. Genetic modification of cold-preserved renal grafts using HSP70 or bcl-2 HVJ-liposome method. Transpl Immunol 2003, 11:7-14.
67. Blydt-Hansen T.D., Katori M., Lassman C., Ke B., Coito A.J., Iyer S., et al. Gene transfer-induced local heme oxygenase-1 overexpression protects rat kidney transplants from ischemia/reperfusion injury. J Am Soc Nephrol 2003, 14:745-754.
68. Tagawa T., Kozower B.D., Kanaan S.A., Daddi N., Suda T., Oka T., et al. Tumor necrosis factor inhibitor gene transfer ameliorates lung graft ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2003, 126:1147-1154.
69. Kang M.Q., Lin P.Q., Lin R.B., Huang X.S., Lin X., Zheng Y.H., et al. Protective effect of ex vivo adenovirus-mediated gene transfer of human interleukin-10 to lung isografts on subsequent ischemia-reperfusion injury: experiment with rats. Natl Med J China 2007, 87:3425-3428.
70. Cooke D.T., Hoyt E.G., Robbins R.C. Overexpression of human Bcl-2 in syngeneic rat donor lungs preserves posttransplant function and reduces intragraft caspase activity and interleukin-1β production. Transplantation 2005, 79:762-767.
71. Kozower B.D., Kanaan S.A., Tagawa T., Suda T., Grapperhaus K., Daddi N., et al. Intramuscular gene transfer of interleukin-10 reduces neutrophil recruitment and ameliorates lung graft ischemia-reperfusion injury. Am J Transplant 2002, 2:837-842.
72. Fischer S., Imai Y., Keshavjee S., Liu M., MacLean A.A., De Perrot M., et al. In vivo transtracheal adenovirus-mediated transfer of human interleukin-10 gene to donor lungs ameliorates ischemia-reperfusion injury and improves early posttransplant graft function in the rat. Hum Gene Ther 2001, 12:1513-1526.
73. Suda T., Mora B.N., D'Ovidio F., Cooper J.A., Hiratsuka M., Zhang W., et al. In vivo adenovirus-mediated endothelial nitric oxide synthase gene transfer ameliorates lung allograft ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2000, 119:297-304.
74. Hiratsuka M., Mora B.N., Yano M., Mohanakumar T., Patterson G.A. Gene transfer of heat shock protein 70 protects lung grafts from ischemia-reperfusion injury. Ann Thorac Surg 1999, 67:1421-1427.
75. Tagawa T., Dharmarajan S., Hayama M., Ishiyama T., Suda T., Itano H., et al. Endobronchial gene transfer of soluble type I interleukin-1 receptor ameliorates lung graft ischemia-reperfusion injury. Ann Thorac Surg 2004, 78:1932-1939.
76. Jiang X., Khan M.A., Tian W., Beilke J., Natarajan R., Kosek J., et al. Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection. J Clin Invest 2011, 121:2336-2349.
77. Lv X., Tan J., Liu D., Wu P., Cui X. Intratracheal administration of p38α short-hairpin RNA plasmid ameliorates lung ischemia-reperfusion injury in rats. J Heart Lung Transplant 2012, 31:655-662.
78. Zhang Y.X., Fan H., Shi Y., Xu S.T., Yuan Y.F., Zheng R.H., et al. Prevention of lung ischemia-reperfusion injury by short hairpin RNA-mediated caspase-3 gene silencing. J Thorac Cardiovasc Surg 2010, 139:758-764.
79. Zhang X., Shan P., Jiang D., Noble P.W., Abraham N.G., Kappas A., et al. Small interfering RNA targeting heme oxygenase-1 enhances ischemia-reperfusion-induced lung apoptosis. J Biol Chem 2004, 279:10677-10684.
80. Singleton P.A., Pendyala S., Gorshkova I.A., Mambetsariev N., Moitra J., Garcia J.G., et al. Dynamin 2 and c-Abl are novel regulators of hyperoxia-mediated NADPH oxidase activation and reactive oxygen species production in caveolin-enriched microdomains of the endothelium. J Biol Chem 2009, 284:34964-34975.
81. Manning E., Pham S., Li S., Vazquez-Padron R.I., Mathew J., Ruiz P., et al. Interleukin-10 delivery via mesenchymal stem cells: a novel gene therapy approach to prevent lung ischemia-reperfusion injury. Hum Gene Ther 2010, 21:713-727.
82. Takayama T., Nishioka Y., Lu L., Lotze M.T., Tahara H., Thomson A.W. Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of t-cell hyporesponsiveness1, 2. Transplantation 1998, 66:1567-1574.
83. Takayama T., Morelli A., Robbins P., Tahara H., Thomson A. Feasibility of CTLA4Ig gene delivery and expression in vivo using retrovirally transduced myeloid dendritic cells that induce alloantigen-specific T cell anergy in vitro. Gene Ther 2000, 7:1265-1273.
84. Hara M., Kingsley C.I., Niimi M., Read S., Turvey S.E., Bushell A.R., et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001, 166:3789-3796.
85. Chai J.-G., Xue S.-a., Coe D., Addey C., Bartok I., Scott D., et al. Regulatory T cells, derived from naive CD4+ CD25-T cells by in vitro Foxp3 gene transfer, can induce transplantation tolerance. Transplantation 2005, 79:1310-1316.
86. Sonntag K.-C., Emery D.W., Yasumoto A., Haller G., Germana S., Sablinski T., et al. Tolerance to solid organ transplants through transfer of MHC class II genes. J Clin Invest 2001, 107:65-71.
87. Tomasoni S., Aiello S., Cassis L., Noris M., Longaretti L., Cavinato R.A., et al. Dendritic cells genetically engineered with adenoviral vector encoding dnIKK2 induce the formation of potent CD4+ T-regulatory cells. Transplantation 2005, 79:1056-1061.
88. Graeb C., Justl M., Scherer M.N., Andrassy J., Frank E., Zuelke C., et al. Use of an adenoviral vector to express soluble donor-major histocompatibility complex molecules capable of suppressing the immune response in rat transplant recipients. Hum Immunol 2002, 63:844-852.
89. Emery D.W., Sablinski T., Shimada H., Germana S., Gianello P., Foley A., et al. Expression of an allogeneic MHC DRB transgene, through retroviral transduction of bone marrow, induces specific reduction of alloreactivity1. Transplantation 1997, 64:1414-1423.
90. Zhu M., Wei M.-F., Liu F., Shi H., Wang G. Interleukin-10 modified dendritic cells induce allo-hyporesponsiveness and prolong small intestine allograft survival. World J Gastroenterol 2003, 9:2509-2512.
91. Min W.-P., Gorczynski R., Huang X.-Y., Kushida M., Kim P., Obataki M., et al. Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival. J Immunol 2000, 164:161-167.
92. O'Rourke R.W., Kang S.-M., Lower J.A., Feng S., Ascher N.L., Baekkeskov S., et al. A dendritic cell line genetically modified to express Ctla4-Ig As A means to prolong islet allograft survival 12. Transplantation 2000, 69:1440-1446.
93. Raper S.E., Chirmule N., Lee F.S., Wivel N.A., Bagg A., Gao G.-p., et al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 2003, 80:148-158.
94. Verma I.M., Weitzman M.D. Gene therapy: twenty-first century medicine. Annu Rev Biochem 2005, 74:711-738.
95. Paredes D., Gambra M., Cervera C., Linares L., Almela M., Rodriguez C., et al. Characterization of the organ donor with bacteremia. Transplantation proceedings 2007, 2083-2085. Elsevier.